# Attaya Suvannasankha, M.D. – FDA Inspection, Apr 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/attaya-suvannasankha-md/6633d92f-0e7f-4c6e-ad3e-7c44212632bd
Source feed: FDA_Inspections

> FDA inspection 1237355 of Attaya Suvannasankha, M.D., April 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237355
- Company Name: Attaya Suvannasankha, M.D.
- Inspection Date: 2024-04-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/daniel-b-bordt/ce6549a6-511f-4e70-af4b-35d690cf69a6)

Company: https://www.keypedia.com/companies/attaya-suvannasankha-md/038dd237-2182-42d4-b324-c973ba02f4f4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c